Efficacy of heat-inactivated hepatitis B vaccine (CLB) in dialysis units
β Scribed by J. Colaert; J. Desmyter; G. Groote; M. Reynders; H. G. J. Brummelhuis; P. J. Dees; P. N. Lelie; E. E. Reerink-Brongers; H. W. Reesink
- Publisher
- Springer Netherlands
- Year
- 1983
- Tongue
- English
- Weight
- 135 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0003-6072
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a randomized, dose-response study among 305 health care workers, we examined whether the immunogenicity of a heat-inactivated hepatitis B vaccine could be enhanced when HBsAg was complexed by anti-HBs contained in hepatitis B immunoglobulin either at equivalent proportions or at 10-fold antigen e
The safety of a plasma-derived hepatitis-B vaccine inactivated by two heating steps (90 sec at 103 "C followed by 10 hr pasteurization at 65 "C) was validated in chimpanzees; 1 O3 chimpanzee-infectious doses (CID,,) of hepatitis-B virus (HBV), subjected to the purification steps during production of
## Abstract A literature search was carried out to investigate the factors that influence the protective efficacy (PE) of hepatitis B vaccines when given to neonates of hepatitis B surface antigen and __e__ antigen positive mothers. Hepatitis B vaccines with either high or low antigen doses are ver
The efficacy of two heating cycles (90 sec at 103 O C and 10 hr at 65 "C) used during manufacture of a plasma-derived hepatitis-B vaccine was validated for the inactivation of 12 virus families. A period of 15 min warming up to 65 O C had already completely inactivated representatives of nine virus